Rate My Professor Jane Hocking

Throughout her distinguished career, Professor Hocking has received numerous accolades, including election as a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS) in 2021, an NHMRC Senior Research Fellowship, and the Dame Kate Campbell Fellowship. Her groundbreaking research has driven significant policy changes, including paradigm shifts in chlamydia management that have influenced global treatment guidelines. She leads an extensive portfolio of projects, such as the Australian Chlamydia Control Effectiveness Pilot (ACCEPt), Removal of Financial Incentives Trial (ACCEPt-able), Rectal Treatment Study (RTS) comparing azithromycin and doxycycline for rectal chlamydia, Management of Chlamydia Cases in Australia (MoCCA), Sexual Health and Ageing, Perspectives and Education (SHAPE) Project, Diagnosis and management of pelvic inflammatory disease in Australia, Optimisation of Treatments for STIs Pharmacokinetics Study (STI-PK), Enhanced syphilis management in general practice, and studies on gonococcal vaccines and COVID-19 impacts on sexual health. Key publications include 'Chlamydia prevention and management in Australia: reducing the burden of disease' (2022), 'Efficacy of interventions to increase the uptake of chlamydia screening' (2011), and features in The Lancet Infectious Diseases (2019). As part of a multidisciplinary team, she contributed to efforts awarded the 2022 Australian Museum Eureka Prize for Research and Innovation.